CSIMarket
 


Allergan plc  (AGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

AGN's EPS from Cont. Operations Growth by Quarter and Year

Allergan Plc's EPS from Cont. Operations results by quarter and year




AGN EPS from Cont. Operations (in $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -0.97 -12.77 10.26
III Quarter September - -2.40 -0.11 -12.05
II Quarter June - -5.37 -1.39 -2.35
I Quarter March 1.15 -7.25 -0.99 -7.85
FY   1.15 -15.99 -15.26 -11.99



AGN EPS from Cont. Operations first quarter 2020 Y/Y Growth Comment
Allergan plc in the first quarter achieved EPS from Cont. Operations of $ 1.15 compare to EPS loss from Cont. Operations recorded in same quarter a year ago.

According to the results reported in the first quarter, Allergan Plc achieved the best EPS from Cont. Operations growth in Biotechnology & Drugs industry. While Allergan Plc' s EPS from Cont. Operations no change of % ranks overall at the positon no. 0 in the first quarter.




AGN EPS from Cont. Operations ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Allergan Plc's first quarter 2020 EPS from Cont. Operations $ 1.15 AGN's Income Statement
Allergan Plc's first quarter 2019 EPS from Cont. Operations $ -7.25 Quarterly AGN's Income Statement
New: More AGN's historic EPS from Cont. Operations Growth >>


AGN EPS from Cont. Operations (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS from Cont. Operations first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
266.67 % 26.15 % -62.86 %
(March 31, 2010)   (June 30. 2005)
EPS from Cont. Operations first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
266.67 % 26.15 % -62.86 %
(March 31, 2010)   (June 30. 2005)

EPS from Cont. Operations by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Allergan Plc's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
342.31 % 23.57 % -70 %
(Sep. 30, 2005)  


AGN's I. Quarter Q/Q EPS from Cont. Operations Comment
This reversal of fortune I. Quarter 2020where Allergan plc delivered EPS from Cont. Operations of $ 1.15 should be beginning of positive business climet.Allergan plc announced in the I. Quarter 2020 EPS from Cont. Operations of $ 1.15 compare to EPS loss from Cont. Operations recorded in previos quarter.

Within Biotechnology & Drugs industry Allergan plc achieved highest sequential EPS from Cont. Operations growth. While Allergan Plc's EPS from Cont. Operations growth quarter on quarter, overall rank is 0.


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
342.31 % 23.57 % -70 %
(Sep. 30, 2005)  


AGN's I. Quarter Q/Q EPS from Cont. Operations Comment
Improvement I. Quarter 2020where Allergan plc published EPS from Cont. Operations of $ 1.15 could be beginning of better business climet.Allergan plc announced in the I. Quarter 2020 EPS from Cont. Operations of $ 1.15 compare to EPS loss from Cont. Operations recorded in previos quarter.

Within Biotechnology & Drugs industry Allergan plc achieved highest sequential EPS from Cont. Operations growth. While Allergan Plc's EPS from Cont. Operations growth quarter on quarter, overall rank is 0.


Allergan Plc's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
Cumulative EPS from Cont. Operations 12 Months Ending $ -7.59 $ -15.99 $ -27.79 $ -25.50 $ -21.52
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment


Allergan plc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment


Allergan plc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Biotechnology & Drugs Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
AGN's EPS from Cont. Operations Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for AGN's Competitors
EPS from Cont. Operations Growth for Allergan Plc's Suppliers
EPS from Cont. Operations Growth for AGN's Customers

You may also want to know
AGN's Annual Growth Rates AGN's Profitability Ratios AGN's Asset Turnover Ratio AGN's Dividend Growth
AGN's Roe AGN's Valuation Ratios AGN's Financial Strength Ratios AGN's Dividend Payout Ratio
AGN's Roa AGN's Inventory Turnover Ratio AGN's Growth Rates AGN's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Mar 31 2020
Amgen Inc -3.44%$ -3.438 
Alexion Pharmaceuticals Inc -4.18%$ -4.183 
Baxter International Inc -4.41%$ -4.412 
Pra Health Sciences Inc -4.41%$ -4.412 
Hill rom Holdings Inc -5.41%$ -5.405 
Atrion Corporation-5.70%$ -5.697 
Lifevantage Corp-7.69%$ -7.692 
Mettler toledo International Inc -9.33%$ -9.333 
Charles River Laboratories International inc -9.65%$ -9.649 
Phibro Animal Health Corp-10.81%$ -10.811 
Lemaitre Vascular Inc-11.11%$ -11.111 
Pfizer Inc-11.59%$ -11.594 
Iradimed Corp-11.76%$ -11.765 
Haemonetics Corp-14.29%$ -14.286 
Encompass Health Corporation-16.19%$ -16.190 
Abbott Laboratories-18.42%$ -18.421 
Bio techne Corp-19.49%$ -19.492 
Gilead Sciences Inc -20.65%$ -20.645 
Bio rad Laboratories Inc -20.87%$ -20.875 
Illumina Inc -25.32%$ -25.316 
Universal Health Services Inc-36.19%$ -36.187 
Axon Enterprise inc -36.36%$ -36.364 
Quest Diagnostics Inc-39.34%$ -39.344 
Biotelemetry Inc -40.00%$ -40.000 
Hca Healthcare Inc -43.23%$ -43.234 
Nuvasive Inc-44.44%$ -44.444 
National Vision Holdings Inc -45.45%$ -45.455 
Icu Medical Inc-46.36%$ -46.358 
U S Physical Therapy Inc-48.72%$ -48.718 
Abiomed Inc -56.96%$ -56.960 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AMH's Profile

Stock Price

AMH's Financials

Business Description

Fundamentals

Charts & Quotes

AMH's News

Suppliers

AMH's Competitors

Customers & Markets

Economic Indicators

AMH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071